Work

Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling.

Year: 2003

Type: article

Source: PubMed

Authors: Qing-Bai She, David Solit, Andrea Basso, Mark M Moasser

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1797430954

FWCI: 9.007

Cites: 15

Cited by: 287

Related to: 10